Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Buyback Achievers Invesco ETF (NQ: PKW )

103.89 -0.58 (-0.56%)
Streaming Delayed Price Updated: 10:00 AM EDT, May 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Buyback Achievers Invesco ETF

Netflix, Apple TV+, and Peacock In 1 - Comcast Introduces Discounted 'StreamSaver' Bundle
Comcast will introduce a discounted streaming bundle including Apple TV+, Netflix and Peacock to reduce subscriber churn. Available this month. 
Via Benzinga
Tap The Stock Buyback Trend With PKW ETF
Stock buybacks recently staged a strong comeback from the lull witnessed in 2023. Companies have announced share repurchases of more than $383 billion in the last 13 weeks. 
Via Talk Markets
Cash Burn: 3 Dividend Aristocrats to Dump for Buyback Plays
Discover why it might be time to trade dividend aristocrats for companies with aggressive buyback strategies for better capital gains. 
Via InvestorPlace
Buyback Bonanza: The Top 7 ETFs to Profit From Corporate Cash Splurges
Profit from corporate cash splurges with these top ETFs targeting buyback strategies. Unlock potential gains in a volatile market. 
Via InvestorPlace
Topics ETFs
Comcast's Market Valuation Does Not Reflect Fair Value For It's Significant Growth Portfolio: Analyst
Analyst reiterates Buy rating and $55 price target for Comcast Corp, with $1.2B in commitments for Olympics ads and strong brand partnerships, indicating undervaluation. 
Via Benzinga
Investors Go Into Risk-Off Mode For The Fund-Flows Week
Investors were net purchasers of fund assets (including those of conventional funds and ETFs) for the third week in four, injecting a net $10.8 billion. 
Via Talk Markets
New Buyback Tax May Impact Stock Returns
In August of last year Congress passed the so-called Inflation Reduction Act and included within the Act is a 1% excise tax on the fair market value of stock repurchased by companies effective... 
Via Talk Markets
Etf Battles: Which Stock Buyback And Shareholders Yield ETF Is Superior?
In this episode of ETF Battles, Ron DeLegge @ETFguide referees an audience requested contest between stock buyback and shareholder yield ETFs from Blackrock (DIVB), Cambria (SYLD​​​​​​​) and Invesco... 
Via Talk Markets
ETF Battles: Which Stock Buyback And Shareholder Yield ETF Is Superior?
An audience-requested showdown between lumber-focused ETFs from Blackrock (DIVB), Cambria (SYLD), and Invesco (PKW). 
Via Talk Markets
US Buybacks Reach New Highs Ahead Of Earnings: Reuters
Stock buybacks in the United States appear to be breaking new ground as firms prepare for quarterly earnings season, even as some investors are concerned about the mounting threat... 
Via Benzinga
US Companies See Record Stock Buy Back In 2022 with $319B Authorized YTD: FT
U.S. companies are rushing to repurchase large volumes of shares to take advantage of recent stock market volatility and reassure investors as growth slows, reported... 
Via Benzinga
Why Apple, Microsoft And Other Big Buyback Stocks Are Crushing The S&P 500's Returns
Some long-term valuation models are projecting negative overall returns for the S&P 500 over the next decade. Analysts are expecting rising int... 
Via Benzinga
ETFs to Make the Most of Oracle-Cerner Deal
Here are some ETFs which could be the best way for investors to tap the opportunity arising from the proposed Oracle-Cerner deal. 
Via Talk Markets
Stock Buybacks In Vogue And Those Companies' Stocks Are Outperforming
As the economy has recovered from the pandemic-induced recession, S&P 500 companies' reported earnings hit a record $389.01 billion for the first quarter ending March 31, 2021. This exceeds the... 
Via Talk Markets
Topics Economy Stocks
Exposures Economy US Equities
5 Top ETFs With Exposure To Biogen
Here is a look at five ETFs with large exposure to Biogen shares. 
Via Talk Markets
5 Top ETFs With Exposure To Biogen
For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA. Aducanumab from Biogen Inc (NASDAQ: BIIB) was approved as a drug that... 
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.